Where does Neuboron Medtech Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Neuboron Medtech Ltd. ranks #7,052 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Neuboron Medtech Ltd. hold?

Neuboron Medtech Ltd. holds 47 US utility patents granted between 2018 and 2025, spanning 21 technology areas.

What is Neuboron Medtech Ltd.'s Innovation Score?

Neuboron Medtech Ltd. has an Innovation Score of 43.5 out of 100 (top 28% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Neuboron Medtech Ltd.'s patent grant rate increasing or decreasing?

Neuboron Medtech Ltd.'s recent grant velocity is +300% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Neuboron Medtech Ltd.'s patents?

Neuboron Medtech Ltd.'s patents average 16.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Neuboron Medtech Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Neuboron Medtech Ltd.

Q: What technology areas does Neuboron Medtech Ltd. focus on?

Neuboron Medtech Ltd.'s top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy) with 42 patents. Grants appear in 21 CPC subclasses total.

USPTO PatentsView assignee record - 47 granted patents across 21 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Neuboron ranks #7,052 of 49,997 tracked US assignees by granted-patent volume, with 47 patents across 21 technology areas.

#7,052
of 49,997 US assignees by volume: Top 28%
by Innovation Score (43.5/100): 16.1
avg claims per patent: +300%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R7052 · Foreign Corporation #7,052 · 47 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 47 grants
UPPER-Q #7,052/49,997
PHOTO-FINISH McCormick &
CPC-FOCUS A61N · 21 areas
INNOV-PAR 43.5/100
CLAIMS-RICH 16.1 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +300% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: McCormick & Company, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Cercacor Laboratories · near

44
Kumiai Chemical… · near

44
Neuboron Medtech · this assignee

44
Vaxcel International · near

44
Velo3d · near

44
3D Lighting… · lowest

7

What this shows Neuboron's Innovation Score is 43.5/100 (top 28% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Neuboron's grants concentrate

Neuboron Medtech Ltd. is a focused PatentsView assignee: 21 CPC subclasses with 89.4% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2020 (12 grants) versus a trough of 2 in 2024. By volume, Neuboron sits between McCormick & Company, Inc. and National Institute of Clean-and-Low-Carbon Energy.

Neuboron's three-year grant acceleration

From 2019–2021 to 2022–2024, Neuboron Medtech Ltd. moved from 25 to 16 grants (0.64x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Mccormick &

47
Mettler-toledo In…

47
Mevion Medical Sy…

47
Microchip Technol…

47
Nook Digital

47
Nuovo Pignone SPA

47
Nankai University

47
National Institut…

47
Neuboron Medtech ◀

47

What this shows Neuboron holds 47 patents at rank #7,049, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Neuboron

By rank, the assignees closest to #7,049 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Neuboron's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Neuboron, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (44 here).

Cercacor Laboratories, Inc. 44 Kumiai Chemical Industry Co., Ltd. 44 Velo3d, Inc. 44 Vaxcel International Co., Ltd. 44

Neuboron's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

44 Top 28% higher than 72% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

Neuboron Medtech Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	4	8.5%
2019	5	10.6%
2020	12	25.5%
2021	8	17.0%
2022	6	12.8%
2023	8	17.0%
2024	2	4.3%
2025partial year	2	4.3%

Which technologies does Neuboron Medtech Ltd. patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 42

G21K - Techniques FOR Handling Particles OR Ionising Radiation NOT Otherwise Provided FOR; Irradiation DEVICES; Gamma RAY OR X-ray Microscopes 23

H05H - Plasma Technique ; Production OF Accelerated Electrically-charged Particles OR OF NEUTRONS; Production OR Acceleration OF Neutral Molecular OR Atomic Beams 21

G21G - Conversion OF Chemical ELEMENTS; Radioactive Sources 17

G01T - Measurement OF Nuclear OR X-radiation 7

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 6

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 6

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 5

A61B - DIAGNOSIS; SURGERY; Identification 4

G21F - Protection Against X-radiation, Gamma Radiation, Corpuscular Radiation OR Particle BOMBARDMENT; Treating Radioactively Contaminated MATERIAL; Decontamination Arrangements Therefor 4

C04B - Lime, MAGNESIA; SLAG; CEMENTS; Compositions Thereof, e.g. Mortars, Concrete OR Like Building MATERIALS; Artificial Stone ; Ceramics ; REFRACTORIES; Treatment OF Natural Stone 4

G06T - Image Data Processing OR Generation, IN General 4

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 3

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 3

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 3

Top 15 of 21 technology areas

Where it ranks

Overall rank by patents

#7,052

of 49,997 tracked assignees

Innovation Score

43.5 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Neuboron Medtech Ltd.'s patent record in context - here's where to go next.

Neuboron Medtech Ltd.'s lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 89.4% of its portfolio - see every assignee active in that class. Explore A61N
Ranked #7,052 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Neuboron Medtech Ltd. against McCormick & Company, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 43.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.